News & Updates

Plasma choline pathway metabolites, including choline and betaine, appear to reduce the risks of cardiovascular events and recurrent stroke, as well as offer incremental value in risk discrimination and stratification in patients with ischaemic stroke, suggests a recent study.

Long-term postmarketing data for adjunctive brivaracetam show that its use helps improve seizure control in patients with various epilepsy syndromes, even in those with prior exposure to levetiracetam. However, psychobehavioural adverse events (AEs) occur in one out of ten patients.

Among patients with type 2 diabetes (T2D), women appear to be at greater risk of accelerated cognitive decline than men, as reported in a study. This risk increase can be partly explained by depressive symptoms being greater among women.

Initiating antiplatelet therapy following an intracerebral haemorrhage (ICH) that occurred during antithrombotic use does not lead to recurrent symptomatic ICH, according to extended results of the RESTART* trial.

A healthier overall diet score and higher fibre, fruit, and vegetable scores result in better health outcomes in adults with multiple sclerosis (MS), according to a study, noting a much lower proportion of participants avoiding dairy and meat or adhering to a specific MS diet than previously reported.

Patients with kidney disease appear to have a slightly elevated risk of dementia, which is driven by vascular dementia, a study suggests.